Reports specify that the presence of BCP mutations affecting HBeAg expression during the acute stage is associated with more severe clinical paths and/or fulminant hepatic failure [38, 39, 40, 41, 42] which emphasizes the need to screen for BCP/PC mutations in infected acute patients. Here, OPN1SW is linked to Fulminant hepatic failure.